Brief: HBM Says FDA Of United States IND Clearance For HBM1020 Clinical Trial Initiation
12/01/2023 15:19
Jan 12 (Reuters) - HBM Holdings 2142.HK :
* FOOD AND DRUG ADMINISTRATION OF UNITED STATES IND
CLEARANCE FOR
HBM1020 CLINICAL TRIAL INITIATION
Further company coverage: 2142.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on HBM Holdings
See all newsBrief: HBM Holdings Says NMPA Approves Batoclimab Injection For Generalized Myasthenia Gravis
HBM climbs on development of AI biology foundation model
Brief: HBM Holdings' Unit Develops World's First Language Model For Fully Human Heavy-Chain-Only Antibodies
Brief: Hbm Holdings Says Solstice Oncology Launches Series A Financing Round
HK-listed HBM climbs on initiating next phase of asthma drug study